Warburg Pincus agrees to pay $4.5B for Bausch & Lomb

Warburg Pincus has added to its healthcare portfolio with a $4.5 billion deal to buy Bausch & Lomb. While Bausch & Lomb is best known for its line of contact lenses, the company also markets a line of pharmaceuticals used to treat eye conditions. Bausch & Lomb can continue to look at other offers, but would have to pay Warburg Pincus a $40 million breakup fee if the company decides to take another bid.

- here's the report on the buyout from MarketWatch

Suggested Articles

The clamor for more transparency from the leading pandemic vaccine contenders has been getting louder.

The role gives one of the driving forces behind Bristol Myers Squibb’s $74 billion takeover of Celgene the chance to help build biotechs.

The appointment gives Sino-American biotech Brii the experience of a man who helped Gilead launch eight drugs in China in quick succession.